Pear Tree Polaris Small Cap Fund

Pear Tree Polaris Small Cap Fund

USBNX
Pear Tree Polaris Small Cap FundUS flagNASDAQ
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Asset Management
Address
LINCOLN NE 01773 Lincoln NE United States of America 01773
IPO Date
Aug 3, 1992
Business
Pear Tree Polaris Small Cap Fund (USBNX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in domestic small capitalization equity securities with market capitalizations generally between $250 million and $5 billion at the time of purchase; it offers Ordinary Shares (USBNX, inception August 3, 1992, minimum investment $2,500, net expense ratio 1.42%), Institutional Shares (QBNAX, inception January 6, 1993, minimum investment $1,000,000, net expense ratio 1.08%), and R6 Shares (QBNRX). The Fund employs a bottom-up investment process combining proprietary quantitative models to screen and rank publicly traded small cap companies based on value metrics, supplemented by in-depth fundamental analysis of cash flows, financials, and business prospects; risk controls limit sector concentrations, with typical holdings numbering 55-57 stocks diversified across financials (approximately 26%), industrials (19%), information technology (11%), consumer discretionary (9%), real estate (8%), health care, materials, consumer staples, energy, and utilities. Subadvised since January 1, 2015 by Polaris Capital Management, LLC, a Boston, Massachusetts-based firm founded in 1995 with over 40 years of collective experience in global, international, and domestic equity management; portfolio managers include Bernard R. Horn, Jr., Bin Xiao, CFA, and Jason Crawshaw; the Fund benchmarks against the Russell 2000 Index and distributed dividends, short-term capital gains, and long-term capital gains in recent years, including $0.1028 dividend and $0.7808 long-term gain per share in 2024 for Ordinary Shares. Headquartered at 55 Old Bedford Road, Suite 202, Lincoln, Massachusetts 01773 under Pear Tree Advisors, Inc., the Fund targets institutional and individual investors seeking exposure to undervalued U.S. small cap growth potential, with net assets around $92-94 million and annual turnover of 49%; top holdings as of late 2025 include CVR Energy Inc., Laureate Education Inc., Perdoceo Education Corp., MKS Instruments Inc., Ingles Markets Inc., Black Hills Corp., EVERTEC Inc., ePlus Inc., South Plains Financial Inc., and Netstreit Corp., representing about 24% of assets, with primarily U.S. allocations (89-90%) plus minor exposures to Puerto Rico, Bermuda, Canada, and Colombia. Recent portfolio changes within 2025 include sales of AirLease Corp. following its all-cash takeover at a 14% premium by a private equity consortium, Regal Rexnord, Tecnoglass, NOV Inc., Science Applications International, and Crocs Inc. due to valuation targets or business cycle pressures; Kimball Electronics on fundamental deterioration in auto/industrial segments; and Global Medical REIT replaced by Sabra Health Care REIT for better risk/return in skilled nursing/senior housing; new additions encompass Avnet Inc. for AI-driven semiconductor distribution, Black Hills Corp. (which subsequently acquired NorthWestern Energy), Phillips Edison (grocery-anchored REIT), ANI Pharmaceuticals (rare/orphan disease generics), Lantheus Holdings (cancer/cardio imaging diagnostics), and Abercrombie & Fitch for product assortment expansion.